Maddamsetti, R. et al. Duplicated antibiotic resistance genes reveal ongoing selection and horizontal gene transfer in bacteria. Nat. Commun. 15, 1449 (2024).
Liu, G. & Stokes, J. M. A brief guide to machine learning for antibiotic discovery. Curr. Opin. Microbiol. 69, 102190 (2022).
Naghavi, M. et al. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050. Lancet 404, 1199–1226 (2024).
O’Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations. Review on Antimicrobial Resistance (HM Government & Wellcome Trust, 2014).
Hawkey, P. M. et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party. J. Antimicrob. Chemother. 73, iii2–iii78 (2018).
Tzouvelekis, L. S., Markogiannakis, A., Psichogiou, M., Tassios, P. T. & Daikos, G. L. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin. Microbiol. Rev. 25, 682–707 (2012).
Ordooei Javan, A., Shokouhi, S. & Sahraei, Z. A review on colistin nephrotoxicity. Eur. J. Clin. Pharmacol. 71, 801–810 (2015).
Li, J. et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect. Dis. 6, 589–601 (2006).
Nitzan, O., Elias, M., Peretz, A. & Saliba, W. Role of antibiotics for treatment of inflammatory bowel disease. World J. Gastroenterol. 22, 1078–1087 (2016).
Zangara, M. T., Darwish, L. & Coombes, B. K. Characterizing the pathogenic potential of Crohn’s disease-associated adherent-invasive Escherichia coli. EcoSal Plus 11, eesp-0018-2022 (2023).
Levy, M., Kolodziejczyk, A. A., Thaiss, C. A. & Elinav, E. Dysbiosis and the immune system. Nat. Rev. Immunol. 17, 219–232 (2017).
Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn’s disease. Cell Host Microbe 15, 382–392 (2014).
Baumgart, M. et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn’s disease involving the ileum. ISME J. 1, 403–418 (2007).
Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).
Tang, X. et al. Structural basis for bacterial lipoprotein relocation by the transporter LolCDE. Nat. Struct. Mol. Biol. 28, 347–355 (2021).
Baron, A. P. et al. Probing the catalytic functions of Bub1 kinase using the small molecule inhibitors BAY-320 and BAY-524. eLife 5, e12187 (2016).
King, A. M. et al. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance. Nature 510, 503–506 (2014).
Ricci, D. P. & Silhavy, T. J. The Bam machine: a molecular cooper. Biochim. Biophys. Acta 1818, 1067–1084 (2012).
Blair, J. M. & Piddock, L. J. Structure, function and inhibition of RND efflux pumps in Gram-negative bacteria: an update. Curr. Opin. Microbiol 12, 512–519 (2009).
Cox, G. et al. A common platform for antibiotic dereplication and adjuvant discovery. Cell Chem. Biol. 24, 98–109 (2017).
French, S. et al. Potentiation of antibiotics against Gram-negative bacteria by polymyxin B analogue SPR741 from unique perturbation of the outer membrane. ACS Infect. Dis. 6, 1405–1412 (2020).
Macnair, C. R. & Brown, E. D. Outer membrane disruption overcomes intrinsic, acquired, and spontaneous antibiotic resistance. mBio 11, e01615-20 (2020).
Zurawski, D. V. et al. SPR741, an antibiotic adjuvant, potentiates the in vitro and in vivo activity of rifampin against clinically relevant extensively drug-resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 61, e01239-17 (2017).
Eckburg, P. B. et al. Safety, tolerability, pharmacokinetics, and drug interaction potential of SPR741, an intravenous potentiator, after single and multiple ascending doses and when combined with β-lactam antibiotics in healthy subjects. Antimicrob. Agents Chemother. 63, e00892-19 (2019).
Gill, S. R. et al. Metagenomic analysis of the human distal gut microbiome. Science 312, 1355–1359 (2006).
Liu, G. et al. Deep learning-guided discovery of an antibiotic targeting Acinetobacter baumannii. Nat. Chem. Biol. 19, 1342–1350 (2023).
Breidenstein, E. B. M. et al. SMT-738: a novel small-molecule inhibitor of bacterial lipoprotein transport targeting Enterobacteriaceae. Antimicrob. Agents Chemother. 68, e00695-23 (2024).
Nayar, A. S. et al. Novel antibacterial targets and compounds revealed by a high-throughput cell wall reporter assay. J. Bacteriol. 197, 1726–1734 (2015).
Lorenz, C., Dougherty, T. J. & Lory, S. Correct sorting of lipoproteins into the inner and outer membranes of Pseudomonas aeruginosa by the Escherichia coli LolCDE transport system. mBio 10, e00194-19 (2019).
Nickerson, N. N. et al. A novel inhibitor of the LolCDE ABC transporter essential for lipoprotein trafficking in Gram-negative bacteria. Antimicrob. Agents Chemother. 62, e02151-17 (2018).
Muñoz, K. A. et al. A Gram-negative-selective antibiotic that spares the gut microbiome. Nature 630, 429–436 (2024).
Corso, G., Stärk, H., Jing, B., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at https://arxiv.org/abs/2210.01776 (2022).
Corso, G. et al. Deep confident steps to new pockets: strategies for docking generalization. Preprint at https://arxiv.org/abs/2402.18396 (2024).
Fan, J., Fu, A. & Zhang, L. Progress in molecular docking. Quant. Biol. 7, 83–89 (2019).
Bender, B. J. et al. A practical guide to large-scale docking. Nat. Protoc. 16, 4799–4832 (2021).
Bonev, B., Hooper, J. & Parisot, J. Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method. J. Antimicrob. Chemother. 61, 1295–1301 (2008).
Tokuda, H. & Matsuyama, S. I. Sorting of lipoproteins to the outer membrane in E. coli. Biochim. Biophys. Acta 1693, 5–13 (2004).
Nicholson, W. L. & Maughan, H. The spectrum of spontaneous rifampin resistance mutations in the rpoB gene of Bacillus subtilis 168 spores differs from that of vegetative cells and resembles that of Mycobacterium tuberculosis. J. Bacteriol. 184, 4936–4940 (2002).
Cho, S. H. et al. Detecting envelope stress by monitoring β-barrel assembly. Cell 159, 1652–1664 (2014).
Hussein, N. A. et al. Distinct domains of Escherichia coli IgaA connect envelope stress sensing and down-regulation of the Rcs phosphorelay across subcellular compartments. PLoS Genet. 14, e1007398 (2018).
Peters, J. M. et al. A comprehensive, CRISPR-based functional analysis of essential genes in bacteria. Cell 165, 1493–1506 (2016).
Larson, M. H. et al. CRISPR interference (CRISPRi) for sequence-specific control of gene expression. Nat. Protoc. 8, 2180–2196 (2013).
Lacour, S., Bechet, E., Cozzone, A. J., Mijakovic, I. & Grangeasse, C. Tyrosine phosphorylation of the UDP-glucose dehydrogenase of Escherichia coli is at the crossroads of colanic acid synthesis and polymyxin resistance. PLoS ONE 3, e3053 (2008).
Jayol, A. et al. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin. Antimicrob. Agents Chemother. 58, 4762–4766 (2014).
Dößelmann, B. et al. Rapid and consistent evolution of colistin resistance in extensively drug-resistant Pseudomonas aeruginosa during morbidostat culture. Antimicrob. Agents Chemother. 61, e00043-17 (2017).
Small, C. L. N., Reid-Yu, S. A., McPhee, J. B. & Coombes, B. K. Persistent infection with Crohn’s disease-associated adherent-invasive Escherichia coli leads to chronic inflammation and intestinal fibrosis. Nat. Commun. 4, 1957 (2013).
Shaler, C. R., et al. Psychological stress impairs IL22-driven protective gut mucosal immunity against colonising pathobionts. Nat. Commun. 12, 6664 (2021).
Bernstein, C. N. Antibiotic use and the risk of Crohn’s disease. Gastroenterol. Hepatol. 9, 393–395 (2013).
Oberc, A. M., Fiebig-Comyn, A. A., Tsai, C. N., Elhenawy, W. & Coombes, B. K. Antibiotics potentiate adherent-invasive E. coli infection and expansion. Inflamm. Bowel Dis. 25, 711–721 (2019).
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G. & Carlson, H. A. Binding MOAD (Mother Of All Databases). Proteins 60, 333–340 (2005).
Polizzi, N. F. & DeGrado, W. F. A defined structural unit enables de novo design of small-molecule-binding proteins. Science 369, 1227–1233 (2020).
Catacutan, D. B., Alexander, J., Arnold, A. & Stokes, J. M. Machine learning in preclinical drug discovery. Nat. Chem. Biol. 20, 960–973 (2024).
Wong, F. et al. Discovery of a structural class of antibiotics with explainable deep learning. Nature 626, 177–185 (2023).
Gentile, F. et al. Deep Docking: a deep learning platform for augmentation of structure based drug discovery. ACS Cent. Sci. 6, 939–949 (2020).
Arnold, A., McLellan, S. & Stokes, J. M. How AI can help us beat AMR. NPJ Antimicrob. Resist. 3, 18 (2025).
Swanson, K. et al. Generative AI for designing and validating easily synthesizable and structurally novel antibiotics. Nat. Mach. Intell. 6, 338–353 (2024).
Godinez, W. J. et al. Design of potent antimalarials with generative chemistry. Nat. Mach. Intell. 4, 180–186 (2022).
Shi, C. et al. GraphAF: a flow-based autoregressive model for molecular graph generation. Preprint at https://arxiv.org/abs/2001.09382 (2020).
Hoogeboom, E., Satorras, V. G., Vignac, C. & Welling, M. Equivariant diffusion for molecule generation in 3D. Proc. Mach. Learn. Res. 162, 8867–8887 (2022).
Grisoni, F. et al. Combining generative artificial intelligence and on-chip synthesis for de novo drug design. Sci. Adv. 7, 3338–3349 (2021).
Swanson, K. et al. SyntheMol-RL: a flexible reinforcement learning framework for designing novel and synthesizable antibiotics. Preprint at bioRxiv https://doi.org/10.1101/2025.05.17.654017 (2025).
Mangat, C. S., Bharat, A., Gehrke, S. S. & Brown, E. D. Rank ordering plate data facilitates data visualization and normalization in high-throughput screening. J. Biomol. Screen. 19, 1314–1320 (2014).
Maggiora, G., Vogt, M., Stumpfe, D. & Bajorath, J. Molecular similarity in medicinal chemistry. J. Med. Chem. 57, 3186–3204 (2014).
Sharma, A. & Lal, S. P. Tanimoto based similarity measure for intrusion detection system. J. Inf. Secur. 2, 195–201 (2011).
Zdrazil, B. et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 52, D1180–D1192 (2024).
O’Shea, R. & Moser, H. E. Physicochemical properties of antibacterial compounds: implications for drug discovery. J. Med. Chem. 51, 2871–2878 (2008).
Wang, R., Fang, X., Lu, Y., Yang, C.-Y. & Wang, S. The PDBbind Database: methodologies and updates. J. Med. Chem. 48, 4111–4119 (2005).
Cheng, H. et al. ECOD: an evolutionary classification of protein domains. PLoS Comput. Biol. 10, e1003926 (2014).
Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at bioRxiv https://doi.org/10.1101/2025.06.14.659707 (2025).
Chai Discovery Team et al. Chai-1: decoding the molecular interactions of life. Preprint at bioRxiv https://doi.org/10.1101/2024.10.10.615955 (2024).
McNutt, A. T., Li, Y., Meli, R., Aggarwal, R. & Koes, D. R. GNINA 1.3: the next increment in molecular docking with deep learning. J. Cheminform. 17, 28 (2025).
Riniker, S. & Landrum, G. A. Better informed distance geometry: using what we know to improve conformation generation. J. Chem. Inf. Model. 55, 2562–2574 (2015).
Kolmogorov, M., Yuan, J., Lin, Y. & Pevzner, P. A. Assembly of long, error-prone reads using repeat graphs. Nat. Biotechnol. 37, 540–546 (2019).
Deatherage, D. E. & Barrick, J. E. Identification of mutations in laboratory-evolved microbes from next-generation sequencing data using breseq. Methods Mol. Biol. 1151, 165–188 (2014).
Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114–2120 (2014).
Calvo-Villamañán, A. et al. On-target activity predictions enable improved CRISPR–dCas9 screens in bacteria. Nucleic Acids Res. 48, e64 (2020).
Depardieu, F. & Bikard, D. Gene silencing with CRISPRi in bacteria and optimization of dCas9 expression levels. Methods 172, 61–75 (2020).
Beal, S. L. Ways to fit a PK model with some data below the quantification limit. J. Pharmacokinet. Pharmacodyn. 28, 481–504 (2001).
Dhaliwal, J. et al. Outcomes following acute severe colitis at initial presentation: a multi-centre, prospective, paediatric cohort study. J. Crohns Colitis 18, 233–245 (2024).
Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2012).
Wickham, H. et al. Welcome to the Tidyverse. J. Open Source Softw. 4, 1686 (2019).
McMurdie, P. J. & Holmes, S. phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS ONE 8, e61217 (2013).
Lahti, L. & Shetty, S. Microbiome Analytics (Bioconductor, 2017); https://doi.org/10.18129/B9.bioc.microbiome
Wickham, H. Reshaping data with the reshape Package. J. Stat. Softw. 21, 1–20 (2007).
Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1–48 (2015).
Kuznetsova, A., Brockhoff, P. B. & Christensen, R. H. B. lmerTest Package: tests in linear mixed effects models. J. Stat. Softw. 82, 1–26 (2017).
Searle, S. R., Speed, F. M. & Milliken, G. A. Population marginal means in the linear model: an alternative to least squares means. Am. Stat. 34, 216–221 (1980).
Wright, E. S. Using DECIPHER v2.0 to analyze big biological sequence data in R. R J. 8, 352–359 (2016).
Callahan, B. J. et al. DADA2: high-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016).
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
Stephens, M. False discovery rates: a new deal. Biostatistics https://doi.org/10.1093/biostatistics/kxw041 (2016).
Keseler, I. M. et al. EcoCyc: fusing model organism databases with systems biology. Nucleic Acids Res. 41, D605–D612 (2013).
Karp, P. D. Pathway databases: a case study in computational symbolic theories. Science 293, 2040–2044 (2001).
Karp, P. D. et al. Pathway Tools version 23.0 update: software for pathway/genome informatics and systems biology. Brief. Bioinform. 22, 109–126 (2021).
Source link
